A new publication reviews the dose-dependent role of Omega 3 EPA in Chronic Inflammation

Chronic inflammation is associated with a release of mediators leading to a low‐grade inflammatory situation which can facilitate the progression of Cardiovascular Disease, Rheumatoid arthritis, and Intestinal Bowel disease, among others. 

In those conditions, EPA has demonstrated dose-dependent beneficial effects: a daily intake of >2 g EPA + DHA can modulate inflammatory processes and obtain therapeutic effects.  

This article highlights the importance of a sufficient daily intake of EPA to achieve such therapeutic effects, as they are strictly dose dependent. 

For more details, read the open access paper: https://pubmed.ncbi.nlm.nih.gov/35204743/ 

 or visit our website www.Noventure.com